Evidence map›Paper›PMID 42368160›Full record

ArticleACS omega2026

Organic-Inorganic Hybrid Scaffolds: Manganese-Doped Bioactive Glass Reinforced Carboxymethyl Chitosan-Alginate Composites for Pulp-Dentin Regeneration.

Elham Khoshbin, Hamed Karkehabadi, Esmaeel Sharifi, Amal Mahavi

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elham KhoshbinDepartment of Endodontics, Faculty of Dentistry, Dental Research Center, Hamadan University of Medical Sciences, Hamadan 65178-3-8736, Iran.
Hamed KarkehabadiDepartment of Endodontics, Faculty of Dentistry, Dental Research Center, Hamadan University of Medical Sciences, Hamadan 65178-3-8736, Iran.
Esmaeel SharifiCancer Research Center, Institute of Cancer, Avicenna Health Research Institute, Hamadan University of Medical Sciences, Hamadan 65178-3-8736, Iran.ORCID https://orcid.org/0000-0003-3400-3106
Amal MahaviDepartment of Endodontics, School of Dentistry, Hamadan University of Medical Sciences, Hamadan 65178-3-8736, Iran.ORCID https://orcid.org/0009-0005-4693-0742

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chemical design of organic/inorganic hybrids through sol-gel synthesis and polymer blending enables tailored properties for biomedical applications. Manganese-doped bioactive glass nanoparticles integrated into biopolymer networks provide tunable ion release and biomineralization capacity essential for hard tissue regeneration. Here, we synthesized and characterized different three-dimensional (3D)-printed carboxymethyl chitosan/alginate (CMC/Alg) scaffolds loaded with manganese-doped bioactive glass (Mn-BG) nanoparticles for pulp-dentin regeneration. 3D scaffolds were designed using Bioplotter software and printed with a 3D printer (Abtin, Iran) using homogeneous CMC/Alg mixtures. Mn-BG nanoparticles were synthesized via sol-gel. Nanoparticles and scaffolds were characterized with SEM, EDAX, FTIR, XRD, DLS, and zeta potential. The hemocompatibility, in vitro degradation, biomineralization, cytocompatibility, and stem cell differentiation were evaluated using Human Apical Papilla Stem Cells (SCAPs). Results confirmed successful synthesis of Mn-BG and Mn-BG/CMC/Alg scaffolds with dose-dependent bioactivity. The 1% Mn-BG scaffolds demonstrated optimal cell viability within 5 days, enhanced matrix mineralization over 14 days, and significantly upregulated osteogenic (ALP, BSP) and odontogenic (DSPP, DMP-1) markers (

Identifiers

PMID42368160
PMCPMC13295033

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.